<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>UK-CAB</title>
	<atom:link href="http://www.ukcab.net/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.ukcab.net</link>
	<description>HIV treatment advocates network</description>
	<lastBuildDate>Tue, 15 May 2012 10:13:47 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
		<item>
		<title>Estimating loss to follow up among persons accessing HIV care in England, Wales and Northern Ireland</title>
		<link>http://www.ukcab.net/presentations/estimating-loss-to-follow-up-among-persons-accessing-hiv-care-in-england-wales-and-northern-ireland/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=estimating-loss-to-follow-up-among-persons-accessing-hiv-care-in-england-wales-and-northern-ireland</link>
		<comments>http://www.ukcab.net/presentations/estimating-loss-to-follow-up-among-persons-accessing-hiv-care-in-england-wales-and-northern-ireland/#comments</comments>
		<pubDate>Tue, 15 May 2012 10:05:58 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
		
		<guid isPermaLink="false">http://www.ukcab.net/?post_type=presentation&#038;p=1692</guid>
		<description><![CDATA[Estimating loss to follow up  among persons accessing HIV care in England, Wales and Northern Ireland]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.ukcab.net/wp-content/uploads/2012/04/Loss-to-follow-up.pdf">Estimating loss to follow up  among persons accessing HIV care in England, Wales and Northern Ireland</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/presentations/estimating-loss-to-follow-up-among-persons-accessing-hiv-care-in-england-wales-and-northern-ireland/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>UK-CAB41: TB and HIV</title>
		<link>http://www.ukcab.net/2012/05/uk-cab41-tb-and-hiv/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=uk-cab41-tb-and-hiv</link>
		<comments>http://www.ukcab.net/2012/05/uk-cab41-tb-and-hiv/#comments</comments>
		<pubDate>Fri, 11 May 2012 09:00:04 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
				<category><![CDATA[Meetings]]></category>

		<guid isPermaLink="false">http://www.ukcab.net/?p=1648</guid>
		<description><![CDATA[Programme: 09:30 ­– 09:50 Registration, refreshments and expenses 09:50 – 10:00 Welcome, introductions, UKCAB updates 10:00 – 11:15 TB and HIV: Screening and treatment– Dr Santino Capocci, Royal Free Hospital 11:15 – 11.30 Break 11:30 – 12.15 TB-HIV: Strengthening Community Response. &#8211; Gitau Mburu, Int. HIV/AIDS Alliance 12:15 – 12.45 Company pre-meeting on TMC207 &#8211; [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Programme:</strong></p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top" width="83">09:30 ­– 09:50</td>
<td valign="top" width="340">Registration, refreshments and expenses</td>
</tr>
<tr>
<td valign="top" width="83">09:50 – 10:00</td>
<td valign="top" width="340">Welcome, introductions, UKCAB updates</td>
</tr>
<tr>
<td valign="top" width="83">10:00 – 11:15</td>
<td valign="top" width="340"><strong>TB and HIV: Screening and treatment– </strong>Dr Santino Capocci, Royal Free Hospital</td>
</tr>
<tr>
<td valign="top" width="83">11:15 – 11.30</td>
<td valign="top" width="340"><strong>Break</strong></td>
</tr>
<tr>
<td valign="top" width="83">11:30 – 12.15</td>
<td valign="top" width="340"><strong>TB-HIV: Strengthening Community Response</strong>. &#8211; Gitau Mburu, Int. HIV/AIDS Alliance</td>
</tr>
<tr>
<td valign="top" width="83">12:15 – 12.45</td>
<td valign="top" width="340"><strong>Company pre-meeting on TMC207 &#8211; </strong>Polly Clayden, HIV i-Base</td>
</tr>
<tr>
<td valign="top" width="83">12:45 &#8211; 14:00</td>
<td valign="top" width="340"><strong>Lunch</strong></td>
</tr>
<tr>
<td valign="top" width="83">14:15 &#8211; 15:30</td>
<td valign="top" width="340"><strong>Company meeting: Janssen</strong></td>
</tr>
<tr>
<td valign="top" width="83">15.30 &#8211; 15.35</td>
<td valign="top" width="340"><strong>Break</strong></td>
</tr>
<tr>
<td valign="top" width="83">15:35 – 16:00</td>
<td valign="top" width="340"><strong>UKCAB London drug survey feedback</strong> – Mark Platt<strong></strong></td>
</tr>
<tr>
<td valign="top" width="83">16.00</td>
<td valign="top" width="340">Close</td>
</tr>
</tbody>
</table>
<p><strong>Background reading</strong></p>
<p>What is TB? – Extracted from the i-Base treatment training for advocates<br />
<a href="http://i-base.info/ttfa/5-opportunistic-infections-ois-and-coinfections/5-7-tb">http://i-base.info/ttfa/5-opportunistic-infections-ois-and-coinfections/5-7-tb</a></p>
<p>BHIVA guidelines for the treatment of TB/HIV coinfection 2011:<br />
<a href="http://www.bhiva.org/TB-HIV2011.aspx">http://www.bhiva.org/TB-HIV2011.aspx</a></p>
<p>How TB is treated<br />
<a href="http://www.tbonline.info/posts/2011/9/2/how-tb-treated/">http://www.tbonline.info/posts/2011/9/2/how-tb-treated/</a></p>
<p>Medicines for people with TB &#8211; contains 1<sup>st</sup> line, multi-drug resistant TB and extremely drug resistant TB medicines.  There is also a section on pipeline drugs.<br />
<a href="http://www.tbonline.info/medicines/">http://www.tbonline.info/medicines/</a></p>
<p>Global TB drug pipeline:<br />
<a href="http://www.newtbdrugs.org/pipeline.php">http://www.newtbdrugs.org/pipeline.php</a></p>
<p>Faster conversion rates with TMC-207 versus placebo plus OBT for the treatment of MDR-TB – study on a new drug with the potential to improve both drug-sensitive and multi-drug resistant TB.<br />
<a href="http://i-base.info/htb-south/1330/">http://i-base.info/htb-south/1330/</a></p>
<p>2011 pipeline report: 2nd edition (September 2011) &#8211; covers the most recent and exciting developments in HIV, hepatitis and TB research. [PDF download, 1MB]<br />
<a href="http://i-base.info/home/2011-pipeline-report-2nd-edition-september-2011/">http://i-base.info/home/2011-pipeline-report-2nd-edition-september-2011/</a></p>
<p><strong>TB in our Lives</strong> &#8211; A detailed guide by Treatment Action Campaign in South Africa, with emphasis on coinfection with HIV.  Activists wrote the guide about how TB attacks the body, how it is treated and the things they can do to help fight TB in their communities.</p>
<p>They explain things in a way that makes sense and that is not too technical so that readers can go on and explain about TB to others. The guide has information sheets for people living with TB, support groups and clinics. [PDF download]<br />
<a href="http://www.tac.org.za/community/node/2115">http://www.tac.org.za/community/node/2115</a></p>
<p><strong>Other useful links:</strong><br />
<a href="http://t.ymlp284.net/ebqyapauwbeagaeumataqebu/click.php">http://www.tbalert.org</a><br />
<a href="http://www.thetruthabouttb.org/">http://www.thetruthabouttb.org/</a><br />
<a href="http://www.tballiance.org/">http://www.tballiance.org/</a><br />
<a href="http://www.stoptbuk.org/">http://www.stoptbuk.org/</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/2012/05/uk-cab41-tb-and-hiv/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>UK-CAB40: Gender and HIV Research</title>
		<link>http://www.ukcab.net/2012/05/uk-cab40-gender-and-hiv-research/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=uk-cab40-gender-and-hiv-research</link>
		<comments>http://www.ukcab.net/2012/05/uk-cab40-gender-and-hiv-research/#comments</comments>
		<pubDate>Fri, 11 May 2012 08:30:26 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
				<category><![CDATA[Meetings]]></category>

		<guid isPermaLink="false">http://www.ukcab.net/?p=1630</guid>
		<description><![CDATA[Programme 09:30 – 09:45 Registration, refreshments and expenses 09:45 – 10:00 Welcome, introductions, UKCAB updates, Company pre-meeting 10:00 – 10:30 Gender and HIV research: history and overview – Polly Clayden, HIV i-Base 10:30 – 11.30 Outcomes in HIV positive women – Lucy Campbell, Kings College Hospital 11:30 &#8211; 11:40 Break 11:40 – 12:40 HIV and [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Programme</strong></p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top" width="83">09:30 – 09:45</td>
<td valign="top" width="340">Registration, refreshments and expenses</td>
</tr>
<tr>
<td valign="top" width="83">09:45 – 10:00</td>
<td valign="top" width="340">Welcome, introductions, UKCAB updates, Company pre-meeting</td>
</tr>
<tr>
<td valign="top" width="83">10:00 – 10:30</td>
<td valign="top" width="340"><strong>Gender and HIV research: history and overview</strong> – Polly Clayden, HIV i-Base</td>
</tr>
<tr>
<td valign="top" width="83">10:30 – 11.30</td>
<td valign="top" width="340"><strong>Outcomes in HIV positive women</strong> – Lucy Campbell, Kings College Hospital</td>
</tr>
<tr>
<td valign="top" width="83">11:30 &#8211; 11:40</td>
<td valign="top" width="340"><strong>Break</strong></td>
</tr>
<tr>
<td valign="top" width="83">11:40 – 12:40</td>
<td valign="top" width="340"><strong>HIV and women’s issues</strong> – Prof. Jane Anderson <strong></strong></td>
</tr>
<tr>
<td valign="top" width="83">12:40 &#8211; 14:00</td>
<td valign="top" width="340"><strong>Lunch</strong></td>
</tr>
<tr>
<td valign="top" width="83">14:00 &#8211; 15:30</td>
<td valign="top" width="340"><strong>Company meeting: BMS</strong></td>
</tr>
<tr>
<td valign="top" width="83">15.30 &#8211; 15.35</td>
<td valign="top" width="340"><strong>Break</strong></td>
</tr>
<tr>
<td valign="top" width="83">15:35 – 16:00</td>
<td valign="top" width="340"><strong>London HIV drug prescribing update and survey </strong>–<strong> </strong>Mark Platt</td>
</tr>
<tr>
<td valign="top" width="83"><strong> </strong></td>
<td valign="top" width="340"><strong>UKCAB AOB</strong><strong></strong></td>
</tr>
<tr>
<td valign="top" width="83">16.00</td>
<td valign="top" width="340">Close</td>
</tr>
</tbody>
</table>
<p><strong>Background reading:</strong><br />
1<sup>st</sup> International Workshop on Women From Adolescence through menopause<br />
<a href="http://i-base.info/htb/14456">http://i-base.info/htb/14456</a></p>
<p>The full report from this meeting can be viewed online here:<br />
<a href="http://www.virology-education.com/index.cfm/t/Workshop_materials/vid/7F5C7280-BB2F-AFB8-9E1C67CB7C0278B1">http://www.virology-education.com/index.cfm/t/Workshop_materials/vid/7F5C7280-BB2F-AFB8-9E1C67CB7C0278B1</a><br />
<strong> </strong><br />
Lopinavir/ritonavir LPV/r: women versus men<br />
<a href="http://i-base.info/htb/14454">http://i-base.info/htb/14454</a><br />
An analysis of on efficacy, safety and tolerability of LPV/r in women compared to men</p>
<p>Lessons from GRACE: A US Study Focused on Women Living with HIV<br />
<a href="http://www.thewellproject.org/en_US/Treatment_and_Trials/Things_to_Consider/GRACE_Study.jsp">http://www.thewellproject.org/en_US/Treatment_and_Trials/Things_to_Consider/GRACE_Study.jsp</a><br />
GRACE is the largest HIV/AIDS study to date in North America of HIV treatment experienced women. The study looked at whether darunavir/ritonavir (DRV/r) in combination with other ARVs would have a different effect in women compared to men. Black women were the focus of the GRACE Study because of the disproportionate effect that HIV/AIDS has in this population throughout the US.<br />
It also is reportedly the longest ongoing disease progression study of HIV infection in women.</p>
<p>Quality of life in the GRACE study<br />
<a href="http://i-base.info/htb/14452">http://i-base.info/htb/14452</a><br />
The report looks at the quality of life in the study participants and how it impacted on discontinuing the study and virological response.</p>
<p>Antiretroviral pharmacokinetics in women with undetectable viral load<br />
<a href="http://i-base.info/htb/14450">http://i-base.info/htb/14450</a><br />
Considerations Regarding Antiretroviral Therapy in HIV-positive Women: Pharmacokinetics</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/2012/05/uk-cab40-gender-and-hiv-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>UK-CAB 42: Diagnostics</title>
		<link>http://www.ukcab.net/2012/04/uk-cab-42-diagnostics/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=uk-cab-42-diagnostics</link>
		<comments>http://www.ukcab.net/2012/04/uk-cab-42-diagnostics/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 16:22:40 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
				<category><![CDATA[Meetings]]></category>

		<guid isPermaLink="false">http://www.ukcab.net/?p=1604</guid>
		<description><![CDATA[Programme 09:30­ &#8211; 09:50 Registration, refreshments and expenses 09:50 -10:00 Welcome, introductions, UKCAB updates 10:00 &#8211; 11:45 Patient information security – Nathan Lea, UKCHIC 10.45 &#8211; 11.15 HIV activism at 30 &#8211; Robert James 11:00 &#8211; 11.30 Break 11:30 &#8211; 12.30 HIV Drug resistance – David Dunn, MRC CTU 12:30 &#8211; 13:30 Lunch 13.30 &#8211; [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Programme</strong></p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top" width="83">09:30­ &#8211; 09:50</td>
<td valign="top" width="340">Registration, refreshments and expenses</td>
</tr>
<tr>
<td valign="top" width="83">09:50 -10:00</td>
<td valign="top" width="340">Welcome, introductions, UKCAB updates</td>
</tr>
<tr>
<td valign="top" width="83">10:00 &#8211; 11:45<strong></strong><strong></strong></td>
<td valign="top" width="340"><strong>Patient information security</strong> – Nathan Lea, UKCHIC</td>
</tr>
<tr>
<td valign="top" width="83">10.45 &#8211; 11.15</td>
<td valign="top" width="340"><strong>HIV activism at 30</strong> &#8211; Robert James</td>
</tr>
<tr>
<td valign="top" width="83">11:00 &#8211; 11.30</td>
<td valign="top" width="340"><strong>Break</strong></td>
</tr>
<tr>
<td valign="top" width="83">11:30 &#8211; 12.30</td>
<td valign="top" width="340"><strong>HIV Drug resistance</strong> – David Dunn, MRC CTU</td>
</tr>
<tr>
<td valign="top" width="83">12:30 &#8211; 13:30</td>
<td valign="top" width="340"><strong>Lunch</strong></td>
</tr>
<tr>
<td valign="top" width="83">13.30 &#8211; 14:30</td>
<td valign="top" width="340"><strong>Loss to follow up study</strong> – Roger Pebody(NAM), Hilary Curtis (BHIVA audit), Brian Rice (HPA)</td>
</tr>
<tr>
<td valign="top" width="83">14.30 &#8211; 15.30</td>
<td valign="top" width="340"><strong>Less frequent tests, what impact on HIV care?</strong> – Dr Nashaba Matin, Mortimer Market Centre</td>
</tr>
<tr>
<td valign="top" width="83">15.30 &#8211; 15.35</td>
<td valign="top" width="340"><strong>Break</strong><strong></strong></td>
</tr>
<tr>
<td valign="top" width="83">15:35 &#8211; 16:00</td>
<td valign="top" width="340"><strong></strong> <strong>Patient reporting of medicines-related problems: feedback </strong>– Paul Clift<br />
<strong></strong><strong></strong><strong> </strong><strong>UK-CAB AOB</strong></td>
</tr>
<tr>
<td valign="top" width="83">16.00</td>
<td valign="top" width="340"><strong>Close</strong></td>
</tr>
</tbody>
</table>
<p>Background reading:</p>
<p>Clive Loveday transcript:<br />
<a href="../2002/08/resistance/">http://www.ukcab.net/2002/08/resistance/</a></p>
<p>A view from the lab: interview with Professor Clive Loveday<br />
<a href="http://i-base.info/htb/3512">http://i-base.info/htb/3512</a></p>
<p>Lost to care: the mystery of the disappearing patients<br />
<a href="http://www.aidsmap.com/Lost-to-care-the-mystery-of-the-disappearing-patients/page/1412542/">http://www.aidsmap.com/Lost-to-care-the-mystery-of-the-disappearing-patients/page/1412542/</a> [PDF, 208KB]</p>
<p><a href="http://www.ukcab.net/wp-content/uploads/2012/03/Rice-2011-Loss-to-follow-up-among-adults-attending-HIV-services.pdf">Loss to Follow-Up Among Adults Attending Human Immunodeficiency Virus Services in England, Wales, and Northern Ireland</a> [PDF, 224 KB]</p>
<p><a href="http://www.aidsmap.com/Adherence-and-retention-in-HIV-care-in-resource-limited-settings/page/1761429/">Adherence and retention in HIV care in resource-limited settings</a> [PDF, 80KB]</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/2012/04/uk-cab-42-diagnostics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV Drug Resistance</title>
		<link>http://www.ukcab.net/presentations/hiv-drug-resistance/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=hiv-drug-resistance</link>
		<comments>http://www.ukcab.net/presentations/hiv-drug-resistance/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 16:00:11 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
		
		<guid isPermaLink="false">http://www.ukcab.net/?post_type=presentation&#038;p=1600</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/presentations/hiv-drug-resistance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Loss to follow up study</title>
		<link>http://www.ukcab.net/2012/04/loss-to-follow-up-study/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=loss-to-follow-up-study</link>
		<comments>http://www.ukcab.net/2012/04/loss-to-follow-up-study/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 15:51:23 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
				<category><![CDATA[Meetings]]></category>

		<guid isPermaLink="false">http://www.ukcab.net/?p=1597</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/2012/04/loss-to-follow-up-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Less frequent tests, what impact on HIV care?</title>
		<link>http://www.ukcab.net/presentations/less-frequent-tests-what-impact-on-hiv-care/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=less-frequent-tests-what-impact-on-hiv-care</link>
		<comments>http://www.ukcab.net/presentations/less-frequent-tests-what-impact-on-hiv-care/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 15:45:16 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
		
		<guid isPermaLink="false">http://www.ukcab.net/?post_type=presentation&#038;p=1595</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/presentations/less-frequent-tests-what-impact-on-hiv-care/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patient reporting of medicines-related problems</title>
		<link>http://www.ukcab.net/presentations/patient-reporting-of-medicines-related-problems/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=patient-reporting-of-medicines-related-problems</link>
		<comments>http://www.ukcab.net/presentations/patient-reporting-of-medicines-related-problems/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 15:36:40 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
		
		<guid isPermaLink="false">http://www.ukcab.net/?post_type=presentation&#038;p=1592</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/presentations/patient-reporting-of-medicines-related-problems/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV Activism at 30</title>
		<link>http://www.ukcab.net/presentations/hiv-activism-at-30/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=hiv-activism-at-30</link>
		<comments>http://www.ukcab.net/presentations/hiv-activism-at-30/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 15:33:54 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
		
		<guid isPermaLink="false">http://www.ukcab.net/?post_type=presentation&#038;p=1590</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/presentations/hiv-activism-at-30/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Patient information security</title>
		<link>http://www.ukcab.net/presentations/patient-information-security/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=patient-information-security</link>
		<comments>http://www.ukcab.net/presentations/patient-information-security/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 15:26:54 +0000</pubDate>
		<dc:creator>Memory Sachikonye</dc:creator>
		
		<guid isPermaLink="false">http://www.ukcab.net/?post_type=presentation&#038;p=1581</guid>
		<description><![CDATA[]]></description>
			<content:encoded><![CDATA[]]></content:encoded>
			<wfw:commentRss>http://www.ukcab.net/presentations/patient-information-security/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

